Jul 6, 2026 07:00AM

May 20, 2026 07:00AM

Mar 25, 2026 07:00AM

Mar 23, 2026 07:00AM

Oct 15, 2025 07:00AM

Oct 15, 2025 07:00AM

Sep 25, 2025 07:00AM Algernon Announces CAD $4 Million Non-Dilutive Financing to Open Four Brain-Specific PET Scan Clinics in the U.S. for Early Stage Alzheimer’s Detection

Sep 4, 2025 07:00AM

Sep 4, 2025 07:00AM

May 13, 2025 07:00AM

Jul 16, 2024 08:00AM

Mar 27, 2024 12:04PM

Nov 22, 2023 07:00AM

Jun 27, 2023 07:00AM Algernon Pharmaceuticals Engages Maxim Group to Explore Spin-Off of its Ifenprodil Phase 2 Chronic Cough Drug Development Program

Jan 9, 2023 07:00AM

Dec 5, 2022 07:00AM

Sep 19, 2022 07:00AM

Sep 1, 2022 07:00AM

Jul 18, 2022 08:00AM

Feb 23, 2022 07:00AM

Jan 14, 2022 08:15AM Algernon Pharmaceuticals Announces Positive Feedback from U.S. FDA for Phase 2b Ifenprodil Chronic Cough Study

327,059 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All